Success built on
science and commitment
Science-based development of immunological reagents for the IVD industry and research community
HyTest offers innovative solutions for assay development and research applications by providing high-quality immunological reagents in such areas as cardiac markers, Troponin I and Troponin T, infectious disease antibodies and autoimmune disease reagents.
HyTest R&D specialists maintain close ties with the scientific community and engage in joint research with Finnish and international academic diagnostic research organizations. This is why HyTest is having success in the field of quality antibody production and is number one choice as a cardiac marker supplier.
Stay informed on our latest news!
LambdaGen’s new diagnostic platform allows rapid and reproducible quantification of cTnI from whole serum.
Again this year we had the pleasure to receive the Kauppalehti Achiever Certificate.
HyTest’s revenue at the end of October for the fiscal year 2011-2012 year was 12.7 million euros. Growth over the previous year was record high 25% despite the volatile economy in the EU.
HyTest offers now a monoclonal antibody specific to HbA1c that may be used to develop an ELISA, lateral-flow- or a turbidometric assay.